Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 2007, p. 7819-7825, Vol. 73, No. 24
0099-2240/07/$08.00+0 doi:10.1128/AEM.01919-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Francis Mulholland,1
Jerry M. Wells,1,
David J. Kelly,2
Arnoud H. M. van Vliet,1* and
Nicholas J. Walton1
Institute of Food Research, Norwich Research Park, Colney Lane, Norwich NR4 7UA, United Kingdom,1 Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield S10 2TN, United Kingdom2
Received 21 August 2007/ Accepted 19 October 2007
|
|
|---|
|
|
|---|
7, ferrous iron is rapidly converted into ferric iron (Fe3+), which is almost completely insoluble at a pH of
7. In mammalian tissues, iron is also complexed into hemoglobin, stored intracellularly in ferritin, or chelated by transferrin in serum and by lactoferrin at mucosal surfaces (40). The resulting free-iron concentration is far too low to support bacterial growth, and consequently, bacteria have evolved different mechanisms to acquire host-complexed iron compounds, including siderophore production and outer-membrane transport mechanisms and the production of ferric reductases (1, 9, 40). One process linked with the formation of ferrous iron is ferric reduction by the action of flavin-cofactored ferric reductases (9, 29), which reduce flavins using reduced nicotinamide nucleotides as hydride donors, with the reduced flavins subsequently being used to reduce Fe3+ (15, 29). In a number of pathogenic bacteria, ferric (flavin) reductases have been found to be secreted extracellularly (4, 10, 11, 35), but in general, these proteins are poorly characterized. A close interrelationship of flavin status and iron uptake has been suggested in a wide range of organisms, including yeasts (14), higher plants (30), and mammals (25). A role for ferric reduction and riboflavin in iron uptake was previously suggested for several pathogenic bacteria, including the gastric pathogen Helicobacter pylori, which produces substantially more riboflavin under iron-limited conditions than under iron-replete conditions (6, 13, 41). In addition, ferrous iron uptake was shown to be required for virulence of H. pylori (36).
Campylobacter jejuni is a major cause of food poisoning in the developed parts of the world (39), and its sequelae include Guillain-Barré syndrome, an acute demyelinating disease of the peripheral nervous system (31). C. jejuni is normally found in the avian gut and cecum, and this environment is thought to be low in oxygen, favoring the formation of ferrous iron. While mechanisms for the acquisition of ferric iron complexes (heme, siderophores) by C. jejuni have been described previously (23, 27), it was recently demonstrated that ferrous iron uptake also plays an important role in avian gut colonization by C. jejuni (22).
In view of the importance of ferrous iron uptake in gut colonization by C. jejuni, we have initiated a study investigating the possible role of flavins and ferric reduction in iron uptake in this organism. Analysis of the genome sequence of C. jejuni strain NCTC11168 (17, 24) indicated the presence of two genes (Cj0572 and Cj0996), both designated ribA and both putatively encoding orthologs of GTP cyclohydrolase II, the enzyme that mediates the initial step of riboflavin biosynthesis from GTP (Fig. 1). The Cj0572 protein has also been annotated as a bifunctional RibBA protein, which suggests that it also encodes RibB activity, which is the enzyme 3,4-dihydroxy-2-butanone-4-phosphate synthase that furnishes a four-carbon unit for incorporation into the riboflavin molecule (Fig. 1). In this study, it is demonstrated that the Cj0572 gene encodes the RibB enzyme of C. jejuni, that there are close links between riboflavin synthesis and ferrous and ferric iron acquisition by C. jejuni, and that these pathways are associated with the major iron-responsive regulator Fur.
![]() View larger version (16K): [in a new window] |
FIG. 1. Overview of the different enzymatic steps in the riboflavin biosynthetic pathway resulting in the biosynthesis of riboflavin and the coenzymes FAD and FMN. Two distinct branches of the pathway interact at the formation of 3,4-dihydroxy-2-butanone-4-phosphate (DHBP), which undergoes condensation with 5-amino-6-(5'-phosphoribitylamino)uracil to yield the riboflavin precursor 6,7-dimethyl-8-ribityllumazine. One molecule of riboflavin is formed from one molecule of GTP and two molecules of ribulose-5-phosphate in a series of enzyme-catalyzed reactions. The enzymes and corresponding genes listed are those generally found in E. coli (2, 37). The Cj gene numbers given with the RibA, RibD, RibE, RibC, and RibF steps are based on the annotation of the C. jejuni genome sequence (17, 24) and require experimental validation. The mechanism whereby the DHBP analogue diacetyl can complement an ribB deficiency is indicated by the gray box.
|
|
|
|---|
(Invitrogen) contains riboflavin (0.27 µM) but does not contain any added iron source (3) and supports the growth of C. jejuni (3, 18, 34). Fifty milliliters of standard MEM
or of MEM
without riboflavin (Invitrogen) was routinely supplemented with 20 µM FeCl3 and 20 mM HEPES and shaken at 200 rpm under microaerophilic conditions. Escherichia coli TOP10 (Invitrogen) was used as the host for cloning experiments and was routinely grown at 37°C in Luria-Bertani medium (28). When indicated, growth media were supplemented with kanamycin or ampicillin to final concentrations of 50 µg/ml and 25 µg/ml, respectively.
Construction of riboflavin auxotrophs by disruption of Cj0572.
The Cj0572 gene of C. jejuni strain NCTC11168 was amplified with primers 0571forward and 0573reverse (Table 1) and cloned into pGEM-Teasy (Promega). A BamHI restriction site was introduced by inverse PCR (42) with primers 0572Bamforward and 0572Bamreverse (Table 1). This inverse PCR also deleted a 502-bp internal fragment of the Cj0572 gene, which was subsequently interrupted by insertion of the kanamycin resistance gene from pJMK30 (34) into this unique BamHI site. The resulting plasmids, pCj0572CK and pCj0572KC, were subsequently introduced into C. jejuni NCTC11168 by electroporation (33). Two colonies derived from independent transformations were tested, and both colonies gave identical results in all experiments. Correct allelic replacement of the wild-type Cj0572 gene with the interrupted version was confirmed by PCR with combinations of the primers 0570forward, 0574reverse, CKRout, and CKFout (Table 1).
|
View this table: [in a new window] |
TABLE 1. Oligonucleotide primers used in this study
|
Riboflavin uptake.
The measurement of riboflavin uptake was adapted from the assay of Fe3+ uptake described previously (26). Late-exponential-phase cultures of strains grown in MEM
lacking riboflavin or in MEM
with additional riboflavin supplementation were harvested and washed twice in 50 mM phosphate buffer, pH 7.4. The cells were resuspended in 50 mM phosphate buffer (pH 7.4) to an optical density at 600 nm of 0.8, and 200 µl of this suspension was then added to 1 ml of standard MEM
. Samples were mixed and left to incubate microaerobically at 37°C for 1 to 2 h. The assay was initiated by adding [G-3H]riboflavin (9,874 Bq; Tocris Cookson Ltd., Bristol, United Kingdom). Samples (200 µl) were withdrawn at 1, 5, and 10 min and washed twice with 0.5 ml of 50 mM phosphate buffer (pH 7.4). The pellet was resuspended in 100 µl of Triton X-100 solution (0.5%, vol/vol, in water), mixed with 5 ml of a Quicksafe A scintillant-water cocktail (containing 1 part of scintillant to 10 parts of water, by volume [Zinsser Analytic, Maidenhead, Berks, United Kingdom]), and shaken vigorously. Radioactivity was determined by scintillation counting with radioactively labeled stock solutions as standards.
Fe3+ and Fe2+ uptake.
Iron uptake was measured by an adaptation of previously described methods (26, 36). A stock solution of Fe2+ was prepared by diluting 10 mM FeCl3 10-fold in 1 M ascorbate, and a stock solution of Fe3+ was prepared by diluting 10 mM FeCl3 10-fold into 1 M sodium citrate. 55FeCl3 (Perkin-Elmer, Waltham, MA) was added such that each assay mixture subsequently contained 7,750 Bq (the specific radioactivity therefore varied with the Fe2+ or Fe3+ concentration). Labeled Fe3+ and Fe2+ solutions were prepared and kept overnight at 4°C before use. Nitrilotriacetate (1.2 mM), which prevents nonspecific binding of iron to the bacterial membrane (16), was mixed with MEM
(1 part of nitrilotriacetate solution to 10 parts of medium, by volume) and kept overnight at 37°C before use. Late-exponential-phase cultures were harvested and washed twice in 50 mM phosphate buffer, pH 7.4, and the cells were resuspended in 50 mM phosphate buffer, pH 7.4, to an optical density at 600 nm of 0.8. Two hundred microliters was added to 1.1 ml of the nitrilotriacetate-MEM
solution and incubated microaerobically at 37°C for 1 to 2 h. The assay was initiated by adding the cell suspension in nitrilotriacetate-MEM
to the labeled Fe2+ or Fe3+ solution and mixing it thoroughly. Samples (200 µl) were withdrawn at 1, 5, and 10 min and treated as described above for measurement of riboflavin uptake.
Measurement of Fe3+ reduction.
Fe3+ reduction activity was determined as described previously (36).
Measurement of protein concentrations.
Protein concentrations of cell extracts were determined by a modified Lowry method (21) with bovine serum albumin as the standard.
|
|
|---|
Mutants containing a kanamycin resistance cassette in the Cj0572 gene were readily isolated on media containing high concentrations of riboflavin. Colonies were only recovered on Skirrow agar or blood agar containing >5 µM riboflavin, with the highest numbers of colonies appearing on plates containing 50 µM and 500 µM riboflavin. While mutants in Cj0572 were readily isolated with the antibiotic resistance cassette in either transcriptional orientation, we were unable to isolate Cj0996 mutants, despite repeated attempts (data not shown). This suggests that either the Cj0996 gene product or proteins encoded by genes in the proximity of Cj0996 may be essential for C. jejuni.
The C. jejuni Cj0572 gene encodes a RibB orthologue.
The growth kinetics of the C. jejuni Cj0572 mutant at different levels of riboflavin supplementation was determined with the defined tissue culture medium MEM
(3). Neither of two independent Cj0572 mutants was able to grow satisfactorily in the absence of added Fe3+ in MEM
and required supplementation with FeCl3 to a final concentration of 20 µM (data not shown). Even in the presence of 50 µM or 500 µM riboflavin, the Cj0572 mutant grew slowly compared to the wild-type strain (Fig. 2A). Growth of the Cj0572 mutant was optimal with riboflavin supplementation to 50 and 500 µM, and growth was significantly reduced with 5 and 0.5 µM riboflavin (Fig. 2B). Finally, the presence of the riboflavin precursor molecule diacetyl, an analogue of 3,4-dihydroxy-2-butanone-4-phosphate (2), allowed growth of the Cj0572 mutants and thus could substitute for riboflavin (Fig. 2C). In contrast, neither flavin mononucleotide (FMN) nor flavin adenine dinucleotide (FAD) could support growth (data not shown). The effect of diacetyl supplementation strongly suggests that the Cj0572 gene encodes a RibB orthologue (Fig. 1), and hence we have annotated the Cj0572 gene as ribB and its mutant as an ribB mutant in the remainder of this report.
![]() View larger version (11K): [in a new window] |
FIG. 2. Mutation of the Cj0572 gene in C. jejuni NCTC11168 results in riboflavin auxotrophy, which can be overcome by supplementation with exogenous riboflavin or the riboflavin precursor diacetyl. (A) Growth curves of the wild-type (WT) strain and the ribB (Cj0572) mutant in riboflavin-free MEM with 20 µM FeCl3, with and without supplementation with 500 µM riboflavin. (B) Growth curves of the ribB (Cj0572) mutant strain in riboflavin-free MEM supplemented with 20 µM FeCl3 and a range of riboflavin concentrations. (C) Growth curves of the C. jejuni NCTC11168 wild-type strain (WT) and ribB mutant in response to exogenous diacetyl. Cultures were grown in MEM without riboflavin, supplemented with 20 µM FeCl3 at 37°C, with or without 50 µM diacetyl. Data shown are from two independent growth experiments, each performed in triplicate. Error bars indicate standard deviations.
|
![]() View larger version (20K): [in a new window] |
FIG. 3. Riboflavin uptake by C. jejuni NCTC11168 is iron and riboflavin responsive and is increased in the fur mutant. Shown are rates of tritiated [G-3H]riboflavin uptake in the C. jejuni wild-type strain, ribB mutant, and fur mutant. Cultures were grown in riboflavin-free MEM under iron-limited (1 µM FeCl3; indicated as –iron) and iron-replete (40 µM FeCl3, indicated as +iron) conditions with and without supplementation with 50 µM riboflavin (indicated as –riboflavin and +riboflavin). Data shown are from two independent experiments performed in triplicate. The ribB mutant could not be tested in medium without riboflavin because of the riboflavin auxotrophy; the absence of data for these samples is indicated by asterisks.
|
, respectively). The wild-type strain and the fur mutant were also grown with and without 50 µM riboflavin (Fig. 4), but this was not possible with the ribB mutant because of its requirement for exogenous riboflavin. It was found that the values for Fe3+ uptake were at least as large as those for Fe2+, particularly in the case of the fur mutant, where the Fe3+ uptake values were about twice those of Fe2+ uptake and around two- to fourfold greater than those of Fe3+ uptake in the wild-type strain (Fig. 4). However, there was no appreciable difference between the ribB mutant and the wild-type strain with respect to either Fe2+ uptake or Fe3+ uptake, regardless of the level of Fe3+ under which the cells were grown (Fig. 4). There was therefore no evidence from these studies of any influence of riboflavin status on the uptake of Fe3+ or Fe2+ per se.
![]() View larger version (21K): [in a new window] |
FIG. 4. Ferric and ferrous iron uptake by C. jejuni NCTC11168 is iron and riboflavin responsive and is increased in the fur mutant. Rates of 55Fe2+ (A) and 55Fe3+ (B) uptake in the wild-type, ribB mutant, and fur mutant strains. Cultures were grown in iron-limited (1 µM FeCl3; indicated as –iron) and iron-replete (40 µM FeCl3, indicated as +iron) MEM or in standard (20 µM FeCl3) MEM without and with additional supplementation with 50 µM riboflavin (indicated as –riboflavin and +riboflavin). Data shown are from two independent experiments performed in triplicate. The ribB mutant could not be tested in MEM without added riboflavin because of the riboflavin auxotrophy; the absence of data for this sample is indicated by an asterisk.
|
|
View this table: [in a new window] |
TABLE 2. Fe3+ reduction activity in C. jejuni NCTC11168 and its ribB and fur mutants
|
|
|
|---|
The results presented here show that C. jejuni strain NCTC11168 can grow independently of exogenous riboflavin (Fig. 2A). It is also able to take up riboflavin from the medium, and exogenous riboflavin stimulated the growth of the wild-type and ribB mutant strains (Fig. 2). Riboflavin transport was confirmed directly by demonstrating the uptake of tritiated riboflavin, and rates of riboflavin uptake were somewhat higher in the ribB mutant than in the wild-type strain (Fig. 3). This suggests the possibility that the uptake mechanism—whatever this may be—may be responsive to the cellular demand for riboflavin and to the capability of the cell to fulfill it. In addition, riboflavin uptake in the fur mutant was found to be generally greater than in the wild type or the ribB mutant and unaffected by growth under riboflavin supplementation or under iron-replete conditions, suggesting an involvement of fur in the mechanism. Genes encoding specific bacterial riboflavin transporters (ypaA, ribU, pnuX, impX, and rfnT) have been identified in a number of bacteria, and expression of ypaA was found to be regulated by an RFN element, in concert with regulation of the expression of the rib operon (37); the RibU, YpaA, and PnuX riboflavin transport proteins of Lactococcus lactis, Bacillus subtilis, and Corynebacterium glutamicum, respectively, have recently been studied in detail (8, 12, 38). The genome sequences of C. jejuni, however, do not encode orthologs of these riboflavin transporter systems (17, 20, 24). It will therefore be of considerable interest to investigate further the biochemical and genetic properties of riboflavin uptake in C. jejuni. The results presented here also clearly show that neither FMN nor FAD supports the growth of the ribB mutant, suggesting that neither compound was taken up appreciably by the cells or that neither compound is hydrolyzed to riboflavin itself extracellularly.
Uptake systems potentially responsible for the assimilation of Fe3+ and Fe2+ in C. jejuni have been characterized, and it seems likely that their relative contributions will depend upon the particular iron sources available, the redox potential, and other environmental and physiological variables (18, 22, 23, 26, 32). Irrespective of the form in which iron is assimilated, there is a probable role for ferric (flavin) reductases, acting intracellularly in the case of the uptake of iron as Fe3+ or extracellularly (or periplasmically) in the case of uptake as Fe2+, for example, via the action of the FeoB transporter (22, 36). Riboflavin auxotrophy or (in the wild-type strain) supplementation with exogenous riboflavin had little effect on the uptake of Fe2+ or of Fe3+, but riboflavin auxotrophy was associated with diminished Fe3+ reduction activity. As the amount of riboflavin available to the ribB mutant was much greater than that available to the wild-type cultures (probably because of the supplementation with exogenous riboflavin), a simple insufficiency of riboflavin could not have been responsible for this diminished activity in the auxotrophs. Although riboflavin provided exogenously was sufficient to support the growth of the auxotrophic cultures, it did not support ferric (flavin) reductase activity to the levels of the wild-type strain (Table 2). This suggests that exogenous supplementation with riboflavin can only partially complement the riboflavin auxotrophy of the ribB mutant. This could be for a variety of potential reasons, including repression of the synthesis of ferric (flavin) reductase in the absence of a functioning riboflavin biosynthetic pathway, or conversely, high levels of exogenous riboflavin might act to repress the synthesis of ferric (flavin) reductase. The identity of the putative ferric reductase is still unknown, and there are unfortunately no obvious candidates present in the C. jejuni genome sequence (17, 24).
Our work unequivocally supports the links among riboflavin status, ferric reductase activity, and iron assimilation in C. jejuni, and these relationships are altered in the absence of the Fur iron-responsive regulator (Fig. 5). We have demonstrated riboflavin uptake by this organism and have shown that this process too is connected to regulation by Fur. Exactly how riboflavin uptake might be regulated in response to the cellular demand for riboflavin and to its role in iron assimilation is an intriguing question now demanding further investigation.
![]() View larger version (24K): [in a new window] |
FIG. 5. Graphic representation of our hypothetical model illustrating the proposed links among riboflavin biosynthesis, assimilatory ferric reduction, and iron acquisition in C. jejuni. Riboflavin biosynthesis via RibB (Fig. 1 and 2) or riboflavin uptake (Fig. 3) allows the activation of an as-yet-unknown flavin/ferric reductase, which mediates extracellular or membrane-bound reduction of ferric iron (Fe3+) to ferrous iron (Fe2+) (Table 2) (9, 15, 29). Ferrous iron may subsequently be transported by the Feo ferrous iron transporter system (Fig. 4) (22, 36). The ferric uptake regulator Fur is depicted as a negative regulator both of riboflavin synthesis and of an uncharacterized riboflavin uptake mechanism (Fig. 3 and 4; Table 2). The dashed lines indicate that it is not known whether the observed phenotypes are due to direct or indirect regulation by Fur.
|
We thank J. M. Gee for helpful discussions.
Published ahead of print on 26 October 2007. ![]()
Present address: Trinity College, Adelaide and Meath Hospital, Dublin, Ireland. ![]()
Present address: Animal Sciences Department, Wageningen University, Wageningen, The Netherlands. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»